TADALAFIL | A211298 | UMEDICA LABORATORIES PRIVATE LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ELI LILLY AND COMPANY et al v. UMEDICA LABORATORIES PVT., LTD. 1 patentANDA 211298tadalafil | D.N.J. | 2018-08-02 | Terminated 2019-02-14 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.1582
per ea
Lowest NADAC/Unit
$0.1022
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 75834025001TADALAFIL 20 MG TABLET | $0.1582 | EA | Generic | — | 2026-08-19 |
| 75834024901TADALAFIL 10 MG TABLET | $0.1575 | EA | Generic | — | 2026-08-19 |
| 75834024701TADALAFIL 2.5 MG TABLET | $0.1164 | EA | Generic | — | 2026-08-19 |
| 75834024801TADALAFIL 5 MG TABLET | $0.1022 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.